Publications by authors named "Jeffrey Statland"

Claim this Profile
E
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.
Karlien Mul, Kate Eichinger, Man Hung, Valeria A Sansone, Cynthia Gagnon, Jeffrey M Statland

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Dmitry Vlodavets, Shiwen Wu, Anna Kostera-Pruszczyk, Jong-Hee Chae, Sheffali Gulati, Jeffrey Statland

J Comp Eff Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study using actigraphy to examine activity performance and its relationship with activity capacity in adults with facioscapulohumeral muscular dystrophy.
Nicole T Koopman, Johanna I Hamel, Michaela E Walker, Leann M Lewis, Sandhya Sasidharan, Jeffrey M Statland

J Neuromuscul Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Gang Wu, Wenan Chen, Joanne Wuu, Angita Jain, Jason Myers, Jeffrey Statland

Transl Neurodegener· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrical impedance myography captures features of muscle structure measured by MRI and transcriptomic analysis in facioscapulohumeral muscular dystrophy.
Leo H Wang, Buket Sonbas Cobb, Lara Riem, Olivia DuCharme, Dennis Ww Shaw, Jeffrey M Statland

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study.
Stephanie M Hunn, Lindsay N Alfano, Aileen Jones, Amanda Butler, Linda P Lowes, Jeffrey M Statland

Ann Clin Transl Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophy.
Leo H Wang, Maya N Hatch, Michael P McDermott, William B Martens, Katy Eichinger, Jeffrey M Statland

Neuromuscul Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective observational study of FKRP-related limb-girdle muscular dystrophy R9: A GRASP consortium study.
Lindsay N Alfano, Meredith K James, Kristine Grosfjeld Petersen, Karen Rudolf, John Vissing, Jeffrey M Statland

Ann Clin Transl Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim, Jeffrey Statland

Muscle Nerve· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.
Michael Benatar, Eric A Macklin, Andrea Malaspina, Mary-Louise Rogers, Eran Hornstein, Jeffrey M Statland

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis.
Michael Benatar, Eric A Macklin, Andrea Malaspina, Mary-Louise Rogers, Eran Hornstein, Jeffrey M Statland

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after intervention for enteral nutrition in patients with amyotrophic lateral sclerosis in multidisciplinary clinics.
Timothy Fullam, Suzanne L Hunt, Madison Han, Jacob Denesia, Swathy Chandrashekhar, Jeffrey Statland

Muscle Nerve· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland

Lancet Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Chao-Jen Wong, Seth D Friedman, Lauren Snider, Sean R Bennett, Takako I Jones, Jeffrey M Statland

Hum Mol Genet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme, Jeffrey M Statland

Orphanet J Rare Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal course of cognitive and behavioural changes in motor neuron diseases.
Caroline A McHutchison, Joanne Wuu, Corey T McMillan, Rosa Rademakers, Jeffrey Statland

J Neurol Neurosurg Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagiline.
Simon Witzel, Jeffrey M Statland, Petra Steinacker, Markus Otto, Johannes Dorst

Eur J Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
Anika Varma, Michael S Todinca, Katy Eichinger, Susanne Heininger, Nuran Dilek, Jeffrey Statland

Muscle Nerve· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study.
Amy Doody, Lindsay Alfano, Jordi Diaz-Manera, Linda Lowes, Tahseen Mozaffar, Jeffrey Statland

BMC Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
Richard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, Jan L de Bleecker, Ludo van der Pol, Jeffrey Statland

Brain· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure.
Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Christine Zizzi, Jeffrey Statland

Amyotroph Lateral Scler Frontotemporal Degener· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J Silvestri, Jeffrey M Statland

Eur J Neurol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
Charles A Thornton, Richard Thomas Moxley, Katy Eichinger, Chad Heatwole, Laurence Mignon, Jeffrey M Statland

Lancet Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
Mara S Tihaya, Karlien Mul, Judit Balog, Jessica C de Greef, Stephen J Tapscott, Jeffrey M Statland

Nat Rev Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design.
Chao-Jen Wong, Seth D Friedman, Lauren Snider, Sean R Bennett, Takako I Jones, Jeffrey M Statland

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis